We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBHT icon
1476
JB Hunt Transport Services
JBHT
$25.5B
$18.1M ﹤0.01%
150,307
+5,416
+4% +$583K
CHY
1477
Calamos Convertible and High Income Fund
CHY
$1.01B
$18.1M ﹤0.01%
1,594,938
+43,138
+3% +$441K
DINO icon
1478
HF Sinclair
DINO
$16.3B
$18.1M ﹤0.01%
619,201
+19,416
+3% +$577K
ZYME icon
1479
Zymeworks
ZYME
$1.61B
$18M ﹤0.01%
500,307
+298,202
+148% +$11M
IART icon
1480
Integra LifeSciences
IART
$1.29B
$18M ﹤0.01%
383,433
+6,652
+2% +$327K
CPZ
1481
Calamos Long/Short Equity & Dynamic Income Trust
CPZ
$259M
$18M ﹤0.01%
1,160,721
-20,321
-2% -$308K
SGOL icon
1482
abrdn Physical Gold Shares ETF
SGOL
$6.91B
$18M ﹤0.01%
1,048,174
+157,885
+18% +$2.61M
BRW
1483
Saba Capital Income & Opportunities Fund
BRW
$336M
$17.9M ﹤0.01%
2,200,284
+205,560
+10% +$1.64M
FINX icon
1484
Global X FinTech ETF
FINX
$170M
$17.9M ﹤0.01%
539,086
+18,255
+4% +$541K
SPEU icon
1485
State Street SPDR Portfolio Europe ETF
SPEU
$729M
$17.9M ﹤0.01%
569,835
+215,157
+61% +$6.32M
IYT icon
1486
iShares US Transportation ETF
IYT
$2.26B
$17.9M ﹤0.01%
439,736
-433,364
-50% -$16.4M
MOO icon
1487
VanEck Agribusiness ETF
MOO
$972M
$17.9M ﹤0.01%
297,024
+10,659
+4% +$602K
MASI
1488
DELISTED
Masimo
MASI
$17.8M ﹤0.01%
78,219
+9,599
+14% +$2.11M
NTNX icon
1489
Nutanix
NTNX
$16B
$17.8M ﹤0.01%
751,916
+79,825
+12% +$1.65M
IYM icon
1490
iShares US Basic Materials ETF
IYM
$1.12B
$17.8M ﹤0.01%
199,529
-4,102
-2% -$339K
DFE icon
1491
WisdomTree Europe SmallCap Dividend Fund
DFE
$166M
$17.8M ﹤0.01%
359,392
-439,847
-55% -$20.2M
TCO
1492
DELISTED
Taubman Centers Inc.
TCO
$17.8M ﹤0.01%
471,042
+454,446
+2,738% +$18.6M
NBIX icon
1493
Neurocrine Biosciences
NBIX
$16.8B
$17.8M ﹤0.01%
145,679
+64,248
+79% +$7.1M
SCHA icon
1494
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$17.8M ﹤0.01%
1,086,720
+355,480
+49% +$5.32M
CHU
1495
DELISTED
China Unicom (HONG KONG) Limited
CHU
$17.7M ﹤0.01%
3,252,604
+361,751
+13% +$2.2M
FXR icon
1496
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$728M
$17.7M ﹤0.01%
467,713
-72,243
-13% -$2.52M
RWJ icon
1497
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.05B
$17.7M ﹤0.01%
966,597
-61,863
-6% -$1.03M
CCEP icon
1498
Coca-Cola Europacific Partners
CCEP
$48.3B
$17.6M ﹤0.01%
467,137
-454,782
-49% -$17.8M
MUNI icon
1499
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.06B
$17.6M ﹤0.01%
316,935
+44,077
+16% +$2.42M
CMC icon
1500
Commercial Metals
CMC
$7.6B
$17.6M ﹤0.01%
864,094
+21,201
+3% +$364K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.